177 related articles for article (PubMed ID: 37311667)
21. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
[TBL] [Abstract][Full Text] [Related]
22. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients.
Starrenburg A; Kraaier K; Pedersen S; Scholten M; Van Der Palen J
Pacing Clin Electrophysiol; 2014 Jun; 37(6):768-73. PubMed ID: 24456312
[TBL] [Abstract][Full Text] [Related]
23. Implantable Cardioverter Defibrillator Shocks and Psychological Distress: Examining the Mediating Roles of Implantable Cardioverter Defibrillator-Related Concerns and Perceived Control.
Lee KS; Hammash MH; Kim JH; Kang KW; Miller J; McEvedy SM; Hwang SY; Moser DK
J Cardiovasc Nurs; 2020; 35(1):66-73. PubMed ID: 31441803
[TBL] [Abstract][Full Text] [Related]
24. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
25. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
[TBL] [Abstract][Full Text] [Related]
26. Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD.
F SS; R H; A S; E J; S A; Z H; R N
Curr Cardiol Rep; 2023 Sep; 25(9):1029-1039. PubMed ID: 37486571
[TBL] [Abstract][Full Text] [Related]
27. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
Makki N; Swaminathan PD; Hanmer J; Olshansky B
Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
[TBL] [Abstract][Full Text] [Related]
28. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
[TBL] [Abstract][Full Text] [Related]
29. Patient plus partner trial: A randomized controlled trial of 2 interventions to improve outcomes after an initial implantable cardioverter-defibrillator.
Dougherty CM; Thompson EA; Kudenchuk PJ
Heart Rhythm; 2019 Mar; 16(3):453-459. PubMed ID: 30340060
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneous implantable cardioverter-defibrillator in primary and secondary prevention of sudden cardiac death: A meta-analysis.
León Salas B; Trujillo-Martín MM; García García J; Ramallo Fariña Y; García Quintana A; Quirós López R; Serrano-Aguilar P
Pacing Clin Electrophysiol; 2019 Sep; 42(9):1253-1268. PubMed ID: 31396970
[TBL] [Abstract][Full Text] [Related]
31. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
32. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
[TBL] [Abstract][Full Text] [Related]
33. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.
Olde Nordkamp LR; Postema PG; Knops RE; van Dijk N; Limpens J; Wilde AA; de Groot JR
Heart Rhythm; 2016 Feb; 13(2):443-54. PubMed ID: 26385533
[TBL] [Abstract][Full Text] [Related]
34. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis.
Rordorf R; Casula M; Pezza L; Fortuni F; Sanzo A; Savastano S; Vicentini A
Heart Rhythm; 2021 Mar; 18(3):382-391. PubMed ID: 33212250
[TBL] [Abstract][Full Text] [Related]
36. Psychopathology in patients with ICDs over time: results of a prospective study.
Kapa S; Rotondi-Trevisan D; Mariano Z; Aves T; Irvine J; Dorian P; Hayes DL
Pacing Clin Electrophysiol; 2010 Feb; 33(2):198-208. PubMed ID: 19930108
[TBL] [Abstract][Full Text] [Related]
37. Posttraumatic stress and anxiety in patients with an implantable cardioverter defibrillator: Trajectories and vulnerability factors.
Habibović M; Denollet J; Pedersen SS;
Pacing Clin Electrophysiol; 2017 Jul; 40(7):817-823. PubMed ID: 28432794
[TBL] [Abstract][Full Text] [Related]
38. Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis.
Zeitler EP; Sanders GD; Singh K; Greenfield RA; Gillis AM; Wilkoff BL; Piccini JP; Al-Khatib SM
Europace; 2018 Oct; 20(10):1621-1629. PubMed ID: 30137296
[TBL] [Abstract][Full Text] [Related]
39. The implantable cardioverter defibrillator in congestive heart failure patients in primary prevention: assessment of neuropsychological impact.
Garnero S; Pomero A; Vallauri P; Leto L; Testa M; Feola M
Minerva Cardioangiol; 2014 Aug; 62(4):321-6. PubMed ID: 24825101
[TBL] [Abstract][Full Text] [Related]
40. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.
Vehmeijer JT; Brouwer TF; Limpens J; Knops RE; Bouma BJ; Mulder BJ; de Groot JR
Eur Heart J; 2016 May; 37(18):1439-48. PubMed ID: 26873095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
